R428 (1 μM) significantly reduced the expression of the pro-fibrotic markers ACTA2, COL1A1, and FN1 in HPFs and IPF FBs compared to TGF-β treatment. This evidence concerns the gene COL1A1 and idiopathic pulmonary fibrosis.